Trial Profile
Paroxetine treatment in outpatients with comorbid PTSD [post-traumatic stress disorder] and substance dependence
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs Paroxetine (Primary)
- Indications Post-traumatic stress disorders; Substance-related disorders
- Focus Therapeutic Use
- 09 Oct 2007 Status change from recruiting to completed.
- 18 Oct 2006 New trial record.